[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338476-105":59,"doc-detail-338476-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","berberine-inhibits-colorectal-liver-metastasis-via-modulation-of-tgf-in-a-cecum-transplant-mouse-model","Berberine inhibits colorectal liver metastasis via modulation of TGF-β in a cecum transplant mouse model","","Hepatic metastasis is a primary cause of death in colorectal cancer (CRC). This study tests whether berberine, a main active compound of Coptidis rhizoma, suppresses colon–liver metastasis in an animal model and clarifies mechanisms. CT26 tumors were implanted into the cecum of balb/c mice, with or without 100 mg/kg berberine, and liver metastases were assessed after 21 days. Berberine reduced liver tumor nodules, enhanced E-cadherin, suppressed vimentin/Snail/TGF-β, lowered inflammatory cytokines, inhibited HCT116/R migration and invasion, and linked effects to TGF-β signaling via inhibitor and siRNA.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/berberine-inhibits-colorectal-liver-metastasis-via-modulation-of-tgf-in-a-cecum-transplant-mouse-model/338476/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/berberine-inhibits-colorectal-liver-metastasis-via-modulation-of-tgf-in-a-cecum-transplant-mouse-model/338476.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main goal of this study on berberine?","Question",{"text":113,"@type":114},"To determine whether berberine inhibits colon–liver metastasis in an animal model and to elucidate the underlying mechanisms, focusing on TGF-β signaling and EMT.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were berberine effects evaluated in the mouse model?",{"text":118,"@type":114},"CT26 colon carcinoma tissue was implanted into the cecum of balb/c mice, followed by 21 days of oral berberine administration (100 mg/kg or no treatment), then liver metastasis was assessed.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanisms does the study propose for berberine’s anti-metastatic effect?",{"text":122,"@type":114},"Berberine appears to inhibit EMT through modulation of TGF-β signaling: it increases epithelial marker E-cadherin, suppresses mesenchymal markers (vimentin, Snail), reduces inflammatory cytokines, and inhibits migration and invasion in resistant colon cancer cells.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338476,1790707217,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","Kang et al. European Journal  \nEuropean Journal of Medical Research (2024) 29:552  \n[https://doi.org/10.1186/s40001-024-02122-w](https://doi.org/10.1186/s40001-024-02122-w of Medical Research)[ of Medical Research](https://doi.org/10.1186/s40001-024-02122-w of Medical Research)  \n RESEARCH Open Access  \nBerberine inhibits colorectal liver metastasis   via modulation ofTGF-β in a cecum transplant mouse model  \nYong‑Hwi Kang 1, Jing‑Hua Wang1, Jin‑Seok Lee 1, Seung‑Ju Hwang 1, Nam‑Hun Lee 1,2* and Chang‑Gue Son 1*  \nAbstract  \nBackground Hepatic metastasis is the primary cause of colorectal cancer (CRC)‑induced death. Our previous results showed the anti‑metastatic effects of Coptidis rhizoma using in vitro model.  \nAim The present study aimed to investigate whether berberine, the main active compound of C. rhizoma, inhibits colon–liver metastasis in an animal model, and to elucidate the underlying mechanisms.  \nMethods Murine colon carcinoma (CT26) tumor tissue was implanted into the cecum of balb/c mice with/with‑ out oral administration of berberine (100 mg/kg) for 21 days, after which liver metastasis was evaluated. In addition, the pharmacological actions of berberine were explored using 5‑fluorouracil‑resistant human colon cancer cells (HCT116/R) .  \nResult The administration of berberine significantly decreased the number of tumor nodules in the liver, while sig‑ nificant activation of E‑cadherin (an epithelial marker), and suppression of vimentin, Snail and TGF‑β (mesenchymal markers) were observed in primary colon tumor tissues. Berberine treatment also notably lowered the levels of inflam‑ matory cytokines (TGF‑β, TNF‑ α, IL‑6 and IL‑1β) in the blood. In HCT116/R cells, berberine significantly inhibited migration and invasion and modulated the expression ofTGF‑β and representative molecules related to its pathway. The results obtained with aTGF‑β inhibitor (SB431542) and aTGF‑β siRNA, strongly suggest that the mechanism of action of berberine is linked toTGF‑β signaling.  \nConclusion In conclusion, berberine evidently possess an anti‑colon–liver metastatic effect, and its underlying mechanisms involve the inhibition of epithelial–mesenchymal transition (EMT) through theTGF‑β signaling pathway. Thus, we cautiously propose the pharmacological potential of berberine in drug research studies targeting hepatic metastasis from CRC.  \nKeywords Colorectal cancer, Metastasis, 5‑Fluorouracil, EMT, Berberine, TGF‑β, Drug resistance  \n*Correspondence: Nam‑Hun Lee [nhlee@dju.kr](nhlee@dju.kr)[ ](nhlee@dju.kr)Chang‑Gue Son [ckson@dju.ac.kr](ckson@dju.ac.kr)  \n1 East‑West Cancer Center of Daejeon University, 176 Split 75 Daedeokdae‑Ro Seo‑Gu, Daejeon 35235, Korea  \n2 East‑West Cancer Center, Cheonan Oriental Hospital of Daejeon University, 4, Notaesan‑Ro, Seobuk‑Gu, Cheonan‑Si 31099, Korea  \nIntroduction  \nColorectal cancer (CRC) has emerged as the third most prevalent malignancy and the second leading cause of mortality worldwide [1]. In 2020, there were approximately 1.9 million new CRC diagnoses, with 935,000 reported deaths attributed to the disease [2]. Favorable clinical outcomes rely on early diagnosis and preemptive treatment, however, this is difficult for patients with CRC because of absence of distinct phenotypic symptoms [3].  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution‑NonCommercial‑NoDerivatives 4.0 International License, which permits any non‑commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to","cbCaiccoAr2oMYxe","https://ap.wps.com/l/cbCaiccoAr2oMYxe","pdf",6918005,"English","# Abstract\n## Background\n## Aim\n## Methods\n## Result\n## Conclusion\n# Introduction\n## Colorectal cancer burden and metastatic risk\n## EMT and TGF-β as mechanistic drivers","[{\"question\":\"What is the main goal of this study on berberine?\",\"answer\":\"To determine whether berberine inhibits colon–liver metastasis in an animal model and to elucidate the underlying mechanisms, focusing on TGF-β signaling and EMT.\"},{\"question\":\"How were berberine effects evaluated in the mouse model?\",\"answer\":\"CT26 colon carcinoma tissue was implanted into the cecum of balb/c mice, followed by 21 days of oral berberine administration (100 mg/kg or no treatment), then liver metastasis was assessed.\"},{\"question\":\"What mechanisms does the study propose for berberine’s anti-metastatic effect?\",\"answer\":\"Berberine appears to inhibit EMT through modulation of TGF-β signaling: it increases epithelial marker E-cadherin, suppresses mesenchymal markers (vimentin, Snail), reduces inflammatory cytokines, and inhibits migration and invasion in resistant colon cancer cells.\"}]","Berberine inhibits colorectal liver metastasis via modulation of TGF-β in a cecum transplant mouse model | PDF",1790023776,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/109c871cde3a21d110c83524f08fca13.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37ada8e11d163f60843d4ecaeba7b5ea.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d3438c0c0c0c6aaea77457966781b52.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6598dce358886ac4fd0c492a1794a8a2.webp",980,1301]